Musculoskeletal Diseases

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
1 program
1
ACE-083Phase 11 trial
Active Trials
NCT02257489CompletedEst. Apr 2016
Medacta
MedactaSwitzerland - Castel San Pietro
1 program
NextAR TKA systemN/A1 trial
Active Trials
NCT04844879CompletedEst. Jun 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.ACE-083
MedactaNextAR TKA system

Clinical Trials (2)

NCT02257489Merck & Co.ACE-083

Phase 1 Study of ACE-083 in Healthy Subjects

Start: Sep 2014Est. completion: Apr 2016
Phase 1Completed
NCT04844879MedactaNextAR TKA system

Medacta NextAR TKA Pivotal Trial

Start: May 2021Est. completion: Jun 2024
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space